GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noile-Immune Biotech Inc (TSE:4893) » Definitions » Sale Of Business

Noile-Immune Biotech (TSE:4893) Sale Of Business : 円0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Noile-Immune Biotech Sale Of Business?

Noile-Immune Biotech's sale of business for the three months ended in Mar. 2024 was 円0.0 Mil. It means Noile-Immune Biotech gained 円0.0 Mil from selling business. Noile-Immune Biotech's sale of business for the trailing twelve months (TTM) ended in Mar. 2024 was 円0.0 Mil.

Compared with last quarter (円0.0 Mil in Dec. 2023 ), Noile-Immune Biotech gained the same money from selling business in Mar. 2024 (円0.0 Mil).


Noile-Immune Biotech Sale Of Business Historical Data

The historical data trend for Noile-Immune Biotech's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noile-Immune Biotech Sale Of Business Chart

Noile-Immune Biotech Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Sale Of Business
- - - -

Noile-Immune Biotech Quarterly Data
Dec20 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Business Get a 7-Day Free Trial Premium Member Only - - - - -

Noile-Immune Biotech Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Noile-Immune Biotech Sale Of Business Related Terms

Thank you for viewing the detailed overview of Noile-Immune Biotech's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Noile-Immune Biotech (TSE:4893) Business Description

Traded in Other Exchanges
N/A
Address
2-12-10 Shiba-Daimon, Minato-ku, Tokyo, JPN, 105-0012
Noile-Immune Biotech Inc is engaged in the development of novel cancer immunotherapy including CAR-T cell therapy.

Noile-Immune Biotech (TSE:4893) Headlines

No Headlines